These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23494605)

  • 21. Hypertrophic cardiomyopathy: two homozygous cases with "typical" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy.
    Nanni L; Pieroni M; Chimenti C; Simionati B; Zimbello R; Maseri A; Frustaci A; Lanfranchi G
    Biochem Biophys Res Commun; 2003 Sep; 309(2):391-8. PubMed ID: 12951062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic analysis of monoallelic double MYH7 mutations responsible for familial hypertrophic cardiomyopathy.
    Wang B; Wang J; Wang LF; Yang F; Xu L; Li WX; He Y; Zuo L; Yang QL; Shao H; Hu D; Liu LW
    Mol Med Rep; 2019 Dec; 20(6):5229-5238. PubMed ID: 31638223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Correlation of cardiac troponin T gene mutations to hypertrophic cardiomyopathy in Chinese patients].
    Li M; Cheng K; Wang QB; Zhu WQ; Chen RZ; Ge JB; Chen HZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1589-91. PubMed ID: 21945774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression.
    Keren A; Syrris P; McKenna WJ
    Nat Clin Pract Cardiovasc Med; 2008 Mar; 5(3):158-68. PubMed ID: 18227814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.
    Chida A; Inai K; Sato H; Shimada E; Nishizawa T; Shimada M; Furutani M; Furutani Y; Kawamura Y; Sugimoto M; Ishihara J; Fujiwara M; Soga T; Kawana M; Fuji S; Tateno S; Kuraishi K; Kogaki S; Nishimura M; Ayusawa M; Ichida F; Yamazawa H; Matsuoka R; Nonoyama S; Nakanishi T
    Heart Vessels; 2017 Jun; 32(6):700-707. PubMed ID: 27885498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Screening and analysis of the mutations on beta-myosin heavy chain gene in 3 Chinese families with hypertrophic cardiomyopathy].
    Feng XL; Fan XP; Yang ZW; Yang FH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Feb; 39(2):110-3. PubMed ID: 21426742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy.
    Waldmüller S; Sakthivel S; Saadi AV; Selignow C; Rakesh PG; Golubenko M; Joseph PK; Padmakumar R; Richard P; Schwartz K; Tharakan JM; Rajamanickam C; Vosberg HP
    J Mol Cell Cardiol; 2003 Jun; 35(6):623-36. PubMed ID: 12788380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations.
    Marian AJ; Mares A; Kelly DP; Yu QT; Abchee AB; Hill R; Roberts R
    Eur Heart J; 1995 Mar; 16(3):368-76. PubMed ID: 7789380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel mitochondrial DNA mutations associated with Chinese familial hypertrophic cardiomyopathy.
    Wei YL; Yu CA; Yang P; Li AL; Wen JY; Zhao SM; Liu HX; Ke YN; Campbell W; Zhang YG; Li XH; Liao WQ
    Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):933-9. PubMed ID: 19473338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel missense mutation in cardiac troponin T gene found in Japanese patient with hypertrophic cardiomyopathy.
    Nakajima-Taniguchi C; Matsui H; Fujio Y; Nagata S; Kishimoto T; Yamauchi-Takihara K
    J Mol Cell Cardiol; 1997 Feb; 29(2):839-43. PubMed ID: 9140840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.
    Chiou KR; Chu CT; Charng MJ
    J Cardiol; 2015 Mar; 65(3):250-6. PubMed ID: 25086479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Novel mutations of cardiac troponin T in Chinese patients with hypertrophic cardiomyopathy].
    Yang J; Liu WL; Hu DY; Zhu TG; Yang SN; Li CL; Li L; Sun YH; Xie WL; Yang JG; Li TC; Bian H; Tong QG; Xiao J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):909-14. PubMed ID: 22321274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
    Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
    Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial Hypertrophic Cardiomyopathy - Identification of cause and risk stratification through exome sequencing.
    Biswas A; Das S; Kapoor M; Shamsudheen KV; Jayarajan R; Verma A; Seth S; Bhargava B; Scaria V; Sivasubbu S; Rao VR
    Gene; 2018 Jun; 660():151-156. PubMed ID: 29572196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic disparity and identification of two TNNI3 gene mutations, one novel and one arising de novo, in South African patients with restrictive cardiomyopathy and focal ventricular hypertrophy.
    Mouton JM; Pellizzon AS; Goosen A; Kinnear CJ; Herbst PG; Brink PA; Moolman-Smook JC
    Cardiovasc J Afr; 2015; 26(2):63-9. PubMed ID: 25940119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mutations in beta myosin heavy chain gene: two mutations in Chinese with familial hypertrophic cardiomyopathy and the correlation between the genotype and phenotype].
    Xie WL; Liu WL; Hu DY; Cui W; Zhu TG; Li CL; Sun YH; Li L; Li TC; Bian H; Tong QG
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1610-3. PubMed ID: 15569455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low prevalence and variable clinical presentation of troponin I and troponin T gene mutations in hypertrophic cardiomyopathy.
    Curila K; Benesova L; Penicka M; Minarik M; Zemanek D; Veselka J; Widimsky P; Gregor P
    Genet Test Mol Biomarkers; 2009 Oct; 13(5):647-50. PubMed ID: 19645627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations.
    Havndrup O; Bundgaard H; Andersen PS; Allan Larsen L; Vuust J; Kjeldsen K; Christiansen M
    Cardiovasc Res; 2003 Feb; 57(2):347-57. PubMed ID: 12566107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of Hypertrophic Cardiomyopathy Related Gene Mutations and Clinical Manifestations in Vietnamese Patients With Hypertrophic Cardiomyopathy.
    Tran Vu MT; Nguyen TV; Huynh NV; Nguyen Thai HT; Pham Nguyen V; Ho Huynh TD
    Circ J; 2019 Aug; 83(9):1908-1916. PubMed ID: 31308319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel mutation of the beta myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy.
    Wang J; Xu SJ; Zhou H; Wang LJ; Hu B; Fang F; Zhang XM; Luo YW; He XY; Zhuang SW; Li XM; Liu ZM; Hu DY
    Clin Cardiol; 2009 Sep; 32(9):E16-21. PubMed ID: 19645038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.